- Where are Leapfrog’s 5 ‘F’ hospitals?
- Where are Leapfrog’s 11 straight-‘A’ hospitals?
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- CVS Health beats the Street with $2.9B in Q1 profit
- Rethinking DSOs: Challenging common misconceptions in modern dentistry
- WakeMed CEO says years of talks led to Atrium deal: ‘We’re the smallest health system of the competitive world now in North Carolina’
- 9 behavioral health facility and service closures, layoffs in 2026
- The new class of opioids: 4 things to know
- Maine health system unveils unified brand
- Physicians in Congress propose Medicare payment overhaul
- 2 men sentenced in $522M fraud, kickback scheme
- What 3 ASC leaders are saying about cardiology’s race to outpatient
- Hospital at home linked to better outcomes: 7 notes
- Long-established Florida physician practice acquired
- Facilitating Access to Trump Accounts
- HCA Tennessee hospital taps COO
- WellSpan Health to open 4-room ASC in Pennsylvania
- Colorado hospital names new CEO
- Yale New Haven hospital president to retire
- Ascension Tennessee hospital names COO
- Nurses fret AI overreliance could erode care, call for more guardrails
- Surgery Partners increases same-facility revenue by 4% in Q1: 10 notes
- Fixing Failures to Communicate
- Dr. Nisha D’Silva installed as president of the American Association for Dental, Oral and Craniofacial Research
- PDS Health, CareQuest partner to expand blood pressure screenings in dental offices
- 5 hospitals, health systems investing in ASCs
- Bankruptcy, PE debt and a $3.9B Ascension deal: A 30-year breakdown of AmSurg
- Henry Schein increases global dental sales by 9% in Q1: 7 notes
- Heartland Dental expands in 7 states
- Ohio woman charged with practicing unlicensed dentistry
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- 15 physician deals in 40 days
- Psych hospital eases security tool restrictions after violent incidents
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- TriHealth hospital hit with $10M verdict in psychiatric unit death
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- From 1st-in-state to 1st-in-world: 5 surgical milestones to know
- California hospitals sue Anthem over out-of-network care policy
- 3 dental mergers, acquisitions in April
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- HHS outlines plan to ‘curb psychiatric overprescribing’: 5 things to know
- Former Oklahoma dental assistant sentenced to prison for assaulting patients
- Statement on Proposing Semiannual Reporting
- Transforming Behavioral Healthcare Delivery through the Collaborative Care Model
- Wellstar partners with BD to implement AI-driven medication management system
- Tennessee dental practice to close due to financial strain
- Listen to the Latest ‘KFF Health News Minute’
- Lifepoint Health taps new vice president of finance from Acadia
- UnitedHealthcare to reduce prior auth requirements by 30%
- ‘Retire one-and-done interventions’: Wellstar achieves 40% drop in physician distress
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- Pfizer delivers strong Q1 but keeps guidance steady amid COVID seasonality
- CVS to expand biosimilar formulary adoptions to improve affordability, accessibility
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Novartis to close German manufacturing site, cutting 220 jobs
- BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback
- After Alzheimer's agitation nod, Axsome jacks up Auvelity's peak sales projection to $8B
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- Sanofi expands AI capabilities, investing $294M to scale Toronto hub
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Assort Health rolls out outbound AI agent for personalized patient outreach
- Neurocrine cites work disruption data to make case for timely movement disorder diagnosis
- Eyeing CAR-T autoimmune first, Kyverna hires pharma veteran as CCO
- Newly formed Keenova launches ‘Don't Be a Viking’ campaign for Dupuytren’s contracture
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- Cytokinetics' Myqorzo succeeds in landmark cardiomyopathy trial
- Why state dental boards are scrutinizing DSOs
- Child Mind Institute names chief clinical officer
- UMass Memorial behavioral health provider to lay off 78 employees
- Prolific Machines sets monoclonal antibody manufacturing record with light-controlled platform
- Healthcare Dealmakers—UConn Health grows, Centene subsidiaries merge and more
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- American Hospital Association, West Health Institute partner to help health systems scale new tech
- Alignment CEO expects short delay for CMS' proposed risk adjustment changes
- WakeMed Health's plans to join Atrium Health face swift pushback from NC officials
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- SCOTUS temporarily restores online access to abortion pill after appeals court ruling
- SCOTUS temporarily restores online access to abortion pill after appeals court ruling
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Nearly half of reproductive age women with Medicaid coverage live in states restricting abortion: KFF
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- CDMO Samsung Biologics estimates $102M impact stemming from ongoing union strike
- After March cuts, Novartis trims another 60 roles at US headquarters
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- Bristol Myers Squibb ties science to soccer in World Cup campaign voiced by Ali Krieger
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- She Survived 2 Shootings. Research Helps Explain Why Her Pain Persists Years Later.
- HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
- Amgen channels another $300M into US outlay, bolstering Puerto Rico biologics expansion
- Journalists Share Latest on Baby Formula Safety, Estrogen Patches, and Postcancer Costs
- Prevention Efforts Increasingly See Suicide Through a Broader Lens
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
- FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype
- High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery
- Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination
- Senators introduce clean extension to cost-based payments for some rural hospitals
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Cleveland Clinic taps startup Luminai to test how AI can run hospital operations
- Look out Rexulti, Axsome's Auvelity has its nod for Alzheimer's agitation
- Cardio drug developer Esperion to go private in potential $1.1B buyout by ArchiMed
- Union workers at Korean CDMO Samsung Biologics kick off strike
- Summit's PD-1xVEGF interim trial miss surprises analysts, shares tumble
- Confusion Continues Over Age To Start Breast Cancer Screening, Survey Finds
- Senses, Not Muscles, Key to Speech Recovery After Stroke
- Antibiotics Not Linked To Celiac Disease Risk, Study Argues
- Common Knee Surgery Doesn't Help, Might Actually Make Things Worse, Clinical Trial Reports
- States Rush To Figure Out How To Enforce Trump's Medicaid Work Requirements
- Gavin Newsom, Early Champion of Single-Payer, Moderates in the Face of Fiscal Limits
- Delays in Visa Program Threaten Placement of Hundreds of Doctors in Underserved Areas
- FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug Daraxonrasib
- From Prototype to Production: Building a Validation Strategy That Scales with Manufacturing Volume
- From Prototype to Production: Building a Validation Strategy That Scales with Manufacturing Volume
- Managing AI in Medical Technology: From Innovation to Compliance
- Managing AI in Medical Technology: From Innovation to Compliance
- Seven Things Every Medical Device Manufacturer Must Know Before Integrating AI
- Seven Things Every Medical Device Manufacturer Must Know Before Integrating AI
- New Medical Guidelines Urge More Fiber, Less Bathroom Scrolling on Your Phone
- Sleep and Anxiety Medications in Pregnancy Appear to Pose Little Harm
- Trump's Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Nasal Spray Flu Vaccines Create 'Battlefield' In Adults' Noses
- Prehabilitation Slashes Post-Op Complications By Half, Review Says
- Understanding Emotions Could Be Key To Quelling Chronic Pain
- Meth Caused 1 In 6 Heart Attacks Over A Decade, Study Finds
- Rising Stars: Axplora’s Arsalan Khan gets technical on marketing
- Orchestrating Affordability: The Critical New Role of the Health Plan
- The Case for a More Proactive Payment Integrity Program
- AI Tool May Help Identify ADHD in Kids Long Before Typical Diagnosis
- FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review
- Dementia Screening Safe For Families, Trial Finds
- Online Program Soothes Post-Trauma Stress In Injured Children
This long overdue punishment for the malicious creation of the COVID-19 virus in China seems to be related to a major event upcoming on Monday, January 20th:
BREAKING: HHS Formally Debars EcoHealth Alliance, Dr. Peter Daszak After COVID Select Reveals Pandemic-Era Wrongdoing
WASHINGTON — Today, after an eight-month investigation, the U.S. Department of Health and Human Services (HHS) cut off all funding and formally debarred EcoHealth Alliance Inc. (EcoHealth) and its former President, Dr. Peter Daszak, for five years based on evidence uncovered by the Select Subcommittee on the Coronavirus Pandemic. In a new letter, HHS states “that a period of debarment for Dr. Daszak is necessary to protect the Federal Government’s business interests.” This letter also confirms that EcoHealth terminated Dr. Daszak’s employment effective January 6, 2025. EcoHealth and Dr. Daszak facilitated gain-of-function research in Wuhan, China without proper oversight and willingly violated multiple requirements of its multimillion-dollar National Institutes of Health (NIH) grant.
House Committee on Oversight and Government Reform Chairman James Comer (R-Ky.) issued the following statement in response to the formal debarment:
“Justice for the American people was served today. Bad actor EcoHealth Alliance and its corrupt former President, Dr. Peter Daszak, were formally debarred by HHS for using taxpayer funds to facilitate dangerous gain-of-function research in China. Today’s decision is not only a victory for the U.S. taxpayer, but also for American national security and the safety of citizens worldwide.
“In May 2024, Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup released evidence that EcoHealth repeatedly violated the terms of its NIH grant. EcoHealth routinely ignored government oversight requests, failed to report dangerous gain-of-function experiments conducted at the Wuhan Institute of Virology, and produced a required research report two years late. HHS cited all of these discoveries as key reasons for formally debarring EcoHealth and Dr. Daszak. Given that a lab-related incident involving gain-of-function research is the most likely origin of COVID-19, EcoHealth and its former President should never again receive a single cent from the U.S. taxpayer.”
Read the letter from HHS to Dr. Peter Daszak here.
Read the letter from HHS to EcoHealth Alliance Inc. here.
Read HHS’s Action Referral Memorandum for Dr. Peter Daszak here.
Read HHS’s Action Referral Memorandum for EcoHealth Alliance Inc. here.
Read More:
Hearing Wrap Up: EcoHealth Alliance Should be Criminally Investigated, Formally Debarred
BREAKING: HHS to Debar Dr. Peter Daszak, President of EcoHealth Alliance
EcoHealth Alliance President Peter Daszak to Appear for Public Hearing
President Biden did not pardon Dr. Peter Daszak of EcoHealth Alliance, nor Dr. David Morens, a key Anthony Fauci apparatchik in the January 2025 pardon festival. Dr. Morens has just been indicted for Freedom of Information Act (FOIA) evasion during the COVID origins investigation:
https://thehill.com/policy/healthcare/5852790-david-morens-anthony-fauci-adviser-nih-foia-records/
Former Fauci adviser indicted for attempting to avoid FOIA laws
By Joseph Choi - April 28, 2026The Justice Department (DOJ) on Tuesday announced the indictment of David Morens, a former senior adviser to Dr. Anthony Fauci within the National Institutes of Health, for his alleged scheme to keep public records away from Freedom of Information Act (FOIA) requests.
The DOJ said in a press release that Morens was being charged with “conspiracy against the United States; destruction, alteration, or falsification of records in federal investigations; concealment, removal, or mutilation of records; and aiding and abetting.”
In 2024, the House Select Subcommittee on the Coronavirus Pandemic released evidence of Morens using his personal email, outside the scope of FOIA requests, to discuss NIH grants with the infectious disease group EcoHealth Alliance.
“These allegations represent a profound abuse of trust at a time when the American people needed it most — during the height of a global pandemic,” Acting Attorney General Todd Blanche said in a statement.
“As alleged in the indictment, Dr. Morens and his co-conspirators deliberately concealed information and falsified records in an effort to suppress alternative theories regarding the origins of COVID-19,” he added. “Government officials have a solemn duty to provide honest, well-grounded facts and advice in service of the public interest — not to advance their own personal or ideological agendas.”
Morens’s communications suggested a quid pro quo relationship with the organization though he claimed he used his personal address to avoid “more embarrassment and danger” to the head of EcoHealth when appearing before the subcommittee. The revelations earned him the ire of both Republicans and Democrats on the special subcommittee.
If convicted, he faces up to three years in prison for each count of concealment of records, up to five for conspiracy against the U.S. and up to 20 years for each count of destruction of records
Morens seemed to suggest in some emails that Fauci, the former director of the National Institute of Allergy and Infectious Diseases, was aware of his misconduct. In one exchange, he wrote, “I can either send stuff to Tony on his private gmail, or hand it to him at work or at his house. He is too smart to let colleagues send him stuff that could cause trouble.”
Fauci for his part disavowed Morens, saying that he “knew nothing” of the emails, describing his former colleague as “not an adviser to me on institute policy or other substantive issues.”
“[To] the best of my knowledge I have never conducted official business via my personal email,” he wrote in an opening statement ahead of his own hearing before the subcommittee in 2024.
President Trump’s allies celebrated Morens’s indictment.
“Weaponization of the USG by its senior members in a time of global pandemic, who were entrusted to protect us. They violated that trust and the law- destroyed records the public had every right to see. They covered up and got caught by this @FBI and @TheJusticeDept,” FBI Director Kash Patel wrote on social media.
Rep. James Comer (R-Ky.), former chair of the COVID special subcommittee, said in a statement, “We caught Dr. Morens red-handed as he boasted in emails about how the ‘FOIA lady’ coached him on how to hide records and cover-up information.”
“I applaud the Trump Justice Department for taking action to hold this public official accountable for hiding information from the American people,” Comer continued. “No one is above the law and under the Trump Administration, overdue accountability is finally here.”
Is Dr. Peter Daszak next?
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














